Squarepoint Ops LLC Cyma Bay Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

$57 Billion
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.63 - $24.47 $113,670 - $220,230	-9,000 Reduced 8.81%	93,133 $2.2 Million
Q2 2023 Aug 14, 2023	BUY	$7.47 - $10.95 $61,634 - $90,348	8,251 Added 8.79%	102,133 $1.12 Million
Q1 2023 May 15, 2023	BUY	$5.88 - $9.59 $493,067 - $804,169	83,855 Added 836.29%	93,882 $818,000
Q4 2022 Feb 14, 2023	SELL	$3.22 - $6.27 $24,046 - $46,824	-7,468 Reduced 42.69%	10,027 $62,000
Q3 2022 Nov 14, 2022	BUY	$2.77 - $4.25 $48,461 - $74,353	17,495 New	17,495 $61,000

Q1 2022 May 16, 2022	SELL	$2.77 - $3.64 $28,456 - $37,393	-10,273 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.23 - $4.6 $12,022 - $17,121	-3,722 Reduced 26.6%	10,273 $35,000
Q3 2021 Nov 15, 2021	SELL	$3.47 - $4.42 $101,088 - $128,763	-29,132 Reduced 67.55%	13,995 $51,000
Q2 2021 Aug 16, 2021	SELL	$3.94 - $4.92 $84,883 - $105,996	-21,544 Reduced 33.31%	43,127 $188,000
Q1 2021 May 17, 2021	SELL	$4.23 - $6.55 $376,140 - $582,439	-88,922 Reduced 57.89%	64,671 $294,000
Q4 2020 Feb 16, 2021	BUY	$5.73 - $9.03 $579,257 - $912,860	101,092 Added 192.55%	153,593 $882,000
Q3 2020 Nov 16, 2020	SELL	$3.32 - $7.24 $732,627 - $1.6 Million	-220,671 Reduced 80.78%	52,501 $380,000
Q2 2020 Aug 14, 2020	BUY	$1.41 - $4.25 $131,974 - $397,795	93,599 Added 52.12%	273,172 $953,000
Q1 2020 May 15, 2020	BUY	$1.25 - $2.02 $71,301 - $115,222	57,041 Added 46.55%	179,573 $266,000
Q4 2019 Feb 14, 2020	SELL	$1.33 - $5.93 $295,529 - $1.32 Million	-222,203 Reduced 64.46%	122,532 $240,000
Q3 2019 Nov 14, 2019	BUY	$5.12 - $7.21 $1.77 Million - $2.49 Million	344,735 New	344,735 $1.77 Million
Q2 2019 Aug 14, 2019	SELL	$6.05 - $13.66 $273,429 - $617,363	-45,195 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$8.16 - $13.42 $368,791 - $606,516	45,195 New	45,195 $600,000
Q4 2017 Feb 14, 2018	SELL	$7.67 - $9.31 $280,491 - $340,466	-36,570 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$5.95 - $8.26 $217,591 - $302,068	36,570	36,570 $295,000

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.88M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account